281 related articles for article (PubMed ID: 17272325)
1. Sudden cardiac death in Andersen-Tawil syndrome.
Peters S; Schulze-Bahr E; Etheridge SP; Tristani-Firouzi M
Europace; 2007 Mar; 9(3):162-6. PubMed ID: 17272325
[TBL] [Abstract][Full Text] [Related]
2. Andersen-Tawil syndrome associated with aborted sudden cardiac death: atrial pacing was effective for ventricular arrhythmias.
Kuramoto Y; Furukawa Y; Yamada T; Okuyama Y; Fukunami M
Am J Med Sci; 2012 Sep; 344(3):248-50. PubMed ID: 22739561
[TBL] [Abstract][Full Text] [Related]
3. [QTU pattern in a patient with the Anderson-Tawil syndrome].
Ciurzyński M; Bienias P; Kostera-Pruszczyk A; Pruszczyk P
Kardiol Pol; 2010 Mar; 68(3):339-41; discussion 342. PubMed ID: 20411461
[TBL] [Abstract][Full Text] [Related]
4. Andersen-Tawil syndrome: report of 3 novel mutations and high risk of symptomatic cardiac involvement.
Kostera-Pruszczyk A; Potulska-Chromik A; Pruszczyk P; Bieganowska K; Miszczak-Knecht M; Bienias P; Szczałuba K; Lee HY; Quinn E; Ploski R; Kaminska A; Ptáček LJ
Muscle Nerve; 2015 Feb; 51(2):192-6. PubMed ID: 24861851
[TBL] [Abstract][Full Text] [Related]
5. Lack of any cardiac involvement in a patient with Andersen-Tawil syndrome associated with the c.574A→G mutation in KCNJ2.
Modoni A; Bianchi ML; Vitulano N; Pagliarani S; Perna F; Sanna T; Rizzo V; Silvestri G
Cardiology; 2011; 120(4):200-3. PubMed ID: 22286118
[TBL] [Abstract][Full Text] [Related]
6. T75M-KCNJ2 mutation causing Andersen-Tawil syndrome enhances inward rectification by changing Mg2+ sensitivity.
Tani Y; Miura D; Kurokawa J; Nakamura K; Ouchida M; Shimizu K; Ohe T; Furukawa T
J Mol Cell Cardiol; 2007 Aug; 43(2):187-96. PubMed ID: 17582433
[TBL] [Abstract][Full Text] [Related]
7. Novel de novo mutation in the KCNJ2 gene in a patient with Andersen-Tawil syndrome.
Kim JB; Chung KW
Pediatr Neurol; 2009 Dec; 41(6):464-6. PubMed ID: 19931173
[TBL] [Abstract][Full Text] [Related]
8. Novel mutation in the KCNJ2 gene is associated with a malignant arrhythmic phenotype of Andersen-Tawil syndrome.
Fernlund E; Lundin C; Hertervig E; Kongstad O; Alders M; Platonov P
Ann Noninvasive Electrocardiol; 2013 Sep; 18(5):471-8. PubMed ID: 24047492
[TBL] [Abstract][Full Text] [Related]
9. A novel neuropsychiatric phenotype of KCNJ2 mutation in one Taiwanese family with Andersen-Tawil syndrome.
Chan HF; Chen ML; Su JJ; Ko LC; Lin CH; Wu RM
J Hum Genet; 2010 Mar; 55(3):186-8. PubMed ID: 20111058
[TBL] [Abstract][Full Text] [Related]
10. Andersen-Tawil syndrome with early fixed myopathy.
Lefter S; Hardiman O; Costigan D; Lynch B; McConville J; Hand CK; Ryan AM
J Clin Neuromuscul Dis; 2014 Dec; 16(2):79-82. PubMed ID: 25415519
[TBL] [Abstract][Full Text] [Related]
11. Trafficking-competent and trafficking-defective KCNJ2 mutations in Andersen syndrome.
Ballester LY; Benson DW; Wong B; Law IH; Mathews KD; Vanoye CG; George AL
Hum Mutat; 2006 Apr; 27(4):388. PubMed ID: 16541386
[TBL] [Abstract][Full Text] [Related]
12. KCNJ2 variant of unknown significance reclassified as long QT syndrome causing ventricular fibrillation.
Obeyesekere MN; Klein GJ; Conacher S; Krahn AD
Can J Cardiol; 2011; 27(6):870.e11-3. PubMed ID: 21875779
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of flecainide for ventricular arrhythmias in patients with Andersen-Tawil syndrome with KCNJ2 mutations.
Miyamoto K; Aiba T; Kimura H; Hayashi H; Ohno S; Yasuoka C; Tanioka Y; Tsuchiya T; Yoshida Y; Hayashi H; Tsuboi I; Nakajima I; Ishibashi K; Okamura H; Noda T; Ishihara M; Anzai T; Yasuda S; Miyamoto Y; Kamakura S; Kusano K; Ogawa H; Horie M; Shimizu W
Heart Rhythm; 2015 Mar; 12(3):596-603. PubMed ID: 25496985
[TBL] [Abstract][Full Text] [Related]
14. Andersen-Tawil syndrome: definition of a neurocognitive phenotype.
Yoon G; Quitania L; Kramer JH; Fu YH; Miller BL; Ptácek LJ
Neurology; 2006 Jun; 66(11):1703-10. PubMed ID: 16769944
[TBL] [Abstract][Full Text] [Related]
15. Genotype-phenotype correlations of KCNJ2 mutations in Japanese patients with Andersen-Tawil syndrome.
Haruna Y; Kobori A; Makiyama T; Yoshida H; Akao M; Doi T; Tsuji K; Ono S; Nishio Y; Shimizu W; Inoue T; Murakami T; Tsuboi N; Yamanouchi H; Ushinohama H; Nakamura Y; Yoshinaga M; Horigome H; Aizawa Y; Kita T; Horie M
Hum Mutat; 2007 Feb; 28(2):208. PubMed ID: 17221872
[TBL] [Abstract][Full Text] [Related]
16. Cardiac characteristics and long-term outcome in Andersen-Tawil syndrome patients related to KCNJ2 mutation.
Delannoy E; Sacher F; Maury P; Mabo P; Mansourati J; Magnin I; Camous JP; Tournant G; Rendu E; Kyndt F; Haïssaguerre M; Bézieau S; Guyomarch B; Le Marec H; Fressart V; Denjoy I; Probst V
Europace; 2013 Dec; 15(12):1805-11. PubMed ID: 23867365
[TBL] [Abstract][Full Text] [Related]
17. Andersen-Tawil syndrome: management challenges during pregnancy, labor, and delivery.
Subbiah RN; Gula LJ; Skanes AC; Krahn AD
J Cardiovasc Electrophysiol; 2008 Sep; 19(9):987-9. PubMed ID: 18554214
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic management of ventricular arrhythmias in Andersen-Tawil syndrome.
Maffè S; Paffoni P; Bergamasco L; Dellavesa P; Zenone F; Baduena L; Franchetti Pardo N; Careri G; Facchini E; Sansone V; Parravicini U
J Electrocardiol; 2020; 58():37-42. PubMed ID: 31710873
[TBL] [Abstract][Full Text] [Related]
19. Biophysical and molecular characterization of a novel de novo KCNJ2 mutation associated with Andersen-Tawil syndrome and catecholaminergic polymorphic ventricular tachycardia mimicry.
Barajas-Martinez H; Hu D; Ontiveros G; Caceres G; Desai M; Burashnikov E; Scaglione J; Antzelevitch C
Circ Cardiovasc Genet; 2011 Feb; 4(1):51-7. PubMed ID: 21148745
[TBL] [Abstract][Full Text] [Related]
20. Andersen-Tawil syndrome: clinical and molecular aspects.
Nguyen HL; Pieper GH; Wilders R
Int J Cardiol; 2013 Dec; 170(1):1-16. PubMed ID: 24383070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
